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A B S T R A C T
Screening assays performed against membrane protein targets (e.g. phage display) are hampered by issues
arising from protein expression and puriﬁcation, protein stability in detergent solutions and epitope concealment
by detergent micelles. Here, we have studied a fast and simple method to improve screening against membrane
proteins: spherical-supported bilayer lipid membranes (“SSBLM”). SSBLMs can be quickly isolated via low-speed
centrifugation and redispersed in liquid solutions while presenting the target protein in a native-like lipid en-
vironment. To provide proof-of-concept, SSBLMs embedding the polytopic bacterial nucleoside transporter NupC
were assembled on 100- and 200 nm silica particles. To test speciﬁc binding of antibodies, NupC was tagged with
a poly-histidine epitope in one of its central loops between two transmembrane helices. Fluorescent labelling,
small angle X-ray scattering (SAXS) and cryo-electron microscopy (cryo-EM) were used to monitor formation of
the SSBLMs. Speciﬁc binding of an anti-his antibody and a gold-nitrilotriacetic acid (NTA) conjugate probe was
conﬁrmed with ELISAs and cryo-EM. SSBLMs for screening could be made with puriﬁed and lipid reconstituted
NupC, as well as crude bacterial membrane extracts. We conclude that SSBLMs are a promising new means of
presenting membrane protein targets for (biomimetic) antibody screening in a native-like lipid environment.
Introduction
Encoded by almost one third of archaean, bacterial and eukaryote DNA
[1], membrane proteins represent vital cellular components for all life-
forms. Given their essential roles towards sustaining life, it is unsurprising
that membrane protein pathology accounts for a large number of debili-
tating conditions, such as Bartter syndrome, cardiac arrhythmia and hy-
pertension, congenital deafness and myotonia, cystic ﬁbrosis, epilepsy,
osteoporosis and polycystic kidney disease [2,3]. Their signiﬁcant ther-
apeutic importance has led to many of today's pharmaceuticals targeting
membrane proteins [4,5], with the largest class being the G-protein cou-
pled receptors (GPCRs). However, the discovery of novel membrane pro-
tein binders – including antibody-based medicines that have emerged
throughout the last decade [6] – is not without issue. The high-throughput
protocols employed by the drug discovery industry demand high levels of
expression and purity from their designated screening targets, yet few
membrane proteins can be expressed at high level within their native
membranes. Moreover, the general study of membrane proteins is further
complicated by the fact that advanced research techniques (e.g., kinetic
and ligand-binding characterisation, nuclear magnetic resonance (NMR)
or X-ray crystallography) cannot always be directly performed on crude
cellular membranes and thus require generous amounts of recombinant
protein of high purity and conformational stability, therefore becoming
reliant on identifying optimised expression platforms, a suitable detergent
for the solubilisation and, more often than not, demanding high-
throughput methodologies [7–9].
Unfortunately, systems used in the overproduction of membrane
protein targets rarely express high amounts of recombinant protein
[10], partly due to diﬀerences between the biogenesis pathways of the
host and those of the expression systems and/or the imposed xenobiotic
toxicity [8]. Even following successful expression, membrane proteins
are notoriously diﬃcult to purify via standard techniques such as ion
exchange or hydrophobic interaction and poor overall yields can still be
registered after the inclusion of specialised high-aﬃnity
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chromatography tags [11]. Furthermore, target denaturation is an ever-
present concern after the proteins have been removed from their native
membranes and this is the main reason why detergent solubilisation has
been traditionally used to counter the considerable hydrophobicity and
aggregation tendency of membrane proteins post-puriﬁcation [7,9].
While detergent-solubilised proteins facilitate screening with other
biomolecules such as ligands or inhibitors in solution [12], it is com-
monly desirable to transfer the target proteins into less disruptive en-
vironments, since even the mildest detergents can still lead to the
complete inactivation of the solubilised proteins [7]. Moreover, in the
context of antibody binding studies, detergent micelles can also actively
block potential epitopes on the chosen screening targets and can thus
have a direct negative impact on the discovery of new antibody-based
pharmaceuticals [12,13].
The main objective of the research presented here was therefore to
develop an alternative screening platform based on spherical-supported
bilayer lipid membranes (“SSBLMs”), which can present membrane
protein targets in a native-like lipid environment. SSBLM consist of a
solid spherical core, typically silica, which is coated with lipid mem-
branes. SSBLMs were ﬁrst developed in the 80s and 90s, are well
characterised with spectroscopy and microscopy and their formation
has been well documented (see Ref. [14] for a review on SSBLMs).
SSBLMs have already been reported for several membrane proteins,
such as the multidrug eﬄux pump component OprM [15], bacter-
iorhodopsin [16] or the redox-driven proton pump cytochrome c oxi-
dase [17]. This prompted us to explore whether, by reﬁnement of the
SSBLM format, this technology can be used in assays that require or
select for speciﬁc, high-aﬃnity antibody binding and, eventually,
screening assays. In order to enhance the amount of protein presented
in a screening assay, submicron silica particles were used.
In order to provide proof-of-concept for our proposed screening
platform, the bacterial nucleoside transporter NupC was chosen as the
membrane protein of interest. Involved in active (secondary) transport
of both purine and pyrimidine nucleosides across bacterial inner
membranes (IMs), NupC is a proton-dependent symporter belonging to
the concentrative nucleoside transporter (CNT) family [18–20]. The
protein shares 22–26% amino acid sequence identity with the human
transporters hCNT1-3, which renders it a good model for studying the
transport of the therapeutic nucleoside analogues used in the treatment
of life-threatening viral and neoplastic diseases, such as azidothymidine
and gemcitabine [21]. Since antibody-based pharmaceuticals are typi-
cally expected to target epitopes located in the loop regions of trans-
membrane proteins, a clone of NupC was engineered to feature a His-
tag on one of its central loops, between two transmembrane helices.
This aﬃnity tag allowed for the binding of both anti-His antibodies as
well as gold-conjugated nitrilotriacetic acid (NTA) probes, which
greatly aided us in providing our proof-of-concept.
Here, we show that SSBLMs are a suitable platform for screening
assays and report on technical improvements that are required to re-
duce non-speciﬁc binding of antibodies to the SSBLM particles. Non-
speciﬁc binding of proteins, including antibodies and biomimetic an-
tibodies, can occur if silica particles are not completely coated by the
lipid membranes, exposing some of the bare silica surface [22]. Here,
we show that including liposomes and bovine serum albumin (BSA), but
not detergents, during the incubation steps with antibodies is a simple
and eﬀective strategy to block non-speciﬁc binding. Furthermore, we
show that this method can also be applied when using crude membrane
extracts, negating the need to tag and purify membrane proteins in
screening assays.
Materials and methods
Materials
All chemicals were purchased from Sigma-Aldrich or Melford unless
stated otherwise. His-tagged NupC detection employed HRP-conjugated
mouse IgG1 anti-His antibodies (R&D Systems, MAB050H). Lipid, de-
tergent and related materials included 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphocholine (POPC) lipids (Avanti Polar Lipids, 850457), α-[4-
(1,1,3,3-Tetramethylbutyl)phenyl]-w-hydroxy-poly(oxy-1,2-ethane-
diyl) (Triton X-100) (10% (w/v) solution) (Anatrace, APX100), Bio-
Beads SM-2 adsorbent beads (Bio-Rad, 1523920) and Texas Red 1,2-
Dihexadecanoyl-sn-glycero-3-phosphoethanolamine triethylammonium
salt (TR-DHPE) (Thermo Fisher Scientiﬁc, T1395MP). Silicon dioxide
(SiO2) spheres with diameters of 100- and 200 nm were supplied as
10mg/mL aqueous solutions (nanoComposix, SISN100 and SISN200,
respectively). The peroxidase assay employed a SensoLyte 10-Acetyl-
3,7-dihydroxyphenoxazine (ADHP) peroxidase assay kit (ﬂuorimetric)
(AnaSpec, AS-71111). Cryo-EM materials included 5 nm Ni-NTA-
Nanogold probes (Nanoprobes, 2082) and lacey carbon ﬁlm/copper
mesh cryo-grids (Agar Scientiﬁc, AGS166).
NupC cloning
Both an untagged version (pGJL16) as well as a His-tagged con-
struct, of NupC (pLH13), were used. The plasmid pGJL16 was obtained
by cloning the E. coli nupC gene into a pTTQ18 vector [23] between
EcoRI and HindIII. pTTQ18 features an isopropyl β-D-thiogalactopyr-
anoside (IPTG)-inducible tac promotor [23]. pLH13 was then cloned
from pGJL16 through the insertion of a pentahistidine tag. We pre-
viously reported that cloning a His-tag into either the N- or C-terminus
of NupC prevents its expression [24], hence a pentahistine tag was
inserted in the central cytoplasmic loop between transmembrane (TM)
helices 5 and 6, speciﬁcally between His230 and Glu231. The penta-
histine tag, along with the native His230, thus resulted in 6 consecutive
histidines. In pLH13, Cys96 was also mutated to an Ala to reduce po-
tential dimerisation and aggregation. While the uridine uptake activity
of the internally His-tagged NupC construct was substantially reduced
compared to the wild-type variant, its post-puriﬁcation functionality
was nevertheless retained (unpublished results).
Puriﬁcation of His-tagged NupC
The puriﬁcation of the His-tagged NupC was modiﬁed from Ref.
[24]. pLH13 was transformed into E. coli strain C43 and grown in Ly-
sogeny broth (LB) media supplemented with 100 μg/mL carbenicillin.
C43/pLH13 was cultured as 500mL cultures in 2 L baﬄed ﬂasks at
37 °C with 200 rpm orbital shaking until reaching an OD600nm of∼0.6,
after which expression was induced with 1mM IPTG (Generon) for
another 4 h. The cells were then harvested via centrifugation (9000×g
for 20min) and resuspended in 20mM Tris, 0.5 mM EDTA (pH 7.4)
using volumes ﬁve to six times the weight of the harvested cells. Once
resuspended, the cells were homogenised using an Ultra-Turrax cell
homogeniser and subsequently lysed via two consecutive runs through
a TS5/40/AB/GA cell disrupter (Constant Systems) at 30 kPsi. The lysed
cells were centrifuged at 14,000×g for 45min in order to remove cel-
lular debris. The supernatant was ultracentrifuged at 131,000×g for 2 h
to isolate the bacterial membranes. The protein concentration of the
membrane preparation was determined using the bicinchoninic acid
(BCA) assay. The membranes were solubilised in solubilisation buﬀer
(1% (w/v) n-Dodecyl-β-D-maltoside (DDM), 50mM phosphate buﬀer,
10% (w/v) glycerol, 150mM NaCl, 5 mM imidazole and cOmplete™
(EDTA-free) mini protease inhibitor cocktail, pH 7.4) at 4 °C for 1 h at a
total membrane protein concentration of approximately 5mg/mL. The
solubilised membranes were then ultracentrifuged at 110,000×g for
1 h, after which the insoluble pellet was discarded. The supernatant was
added to a bed volume of 80 μL of cobalt aﬃnity chromatography resin
(Pierce) per 25mg of total membrane protein, pre-equilibrated in wash
buﬀer (50mM phosphate buﬀer, 10% (w/v) glycerol, 150mM NaCl,
5 mM imidazole and 0.05% (w/v) DDM, pH 7.4). NupC was bound to
the resin for 16 h at 4 °C with gentle roller mixing. The resin was packed
into a disposable ﬁltered column (Thermo-Pierce Scientiﬁc) and
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washed at 20 °C with 10 column volumes of wash buﬀer. NupC was
eluted in 0.5 mL fractions using elution buﬀer (50mM phosphate
buﬀer, 10% (w/v) glycerol, 150mM NaCl, 300mM imidazole and
0.05% (w/v) DDM, pH 7.4) and subsequently dialysed for another 16 h
at 4 °C against dialysis buﬀer (50mM MES, 10% (w/v) glycerol,
150mM NaCl and 0.05% (w/v) DDM, pH 6.8). Finally, the protein
samples were concentrated using a Vivaspin concentrator (Sartorius)
with a 10 kDa molecular weight cut oﬀ (MWCO). The concentrated
NupC was snap-frozen in liquid nitrogen and stored at −80 °C.
Liposome preparations
POPC was dissolved in chloroform, distributed into 5mg aliquots
and dried ﬁrst under a nitrogen stream, then under vacuum for 2 h. The
desiccated lipid aliquots were stored under a nitrogen atmosphere at
−20 °C until used. Liposomes were prepared by ﬁrst rehydrating the
above-mentioned aliquots in phosphate-buﬀered saline (PBS), typically
at concentrations of 5mg/mL. The lipid suspensions were then passed
11 times through a fully assembled Mini-Extruder (Avanti Polar Lipids),
ﬁtted with a polycarbonate track-etched membrane (Whatman) fea-
turing either 100 nm or 200 nm pore sizes, sandwiched between four
extruder drain discs (i.e. two on each side of the membrane). The
ﬂuorescent labelling of POPC liposomes was achieved by ﬁrst dissolving
Texas Red (TR)-modiﬁed lipids in a 1:1 (v/v) mixture of chloroform and
methanol (0.5 mg/mL) and adding 100 μL of it to a 5mg POPC aliquot
(i.e. 1% (w/w)) prior to performing the drying and extrusion steps
described above.
Inner membrane extract preparation
C43/pGJL16 was cultured as described above and the total mem-
brane fraction was isolated as for C43/pLH13. Following ultra-
centrifugation, the membrane pellet (i.e., the total membrane extract)
was resuspended in a 25% (w/w) sucrose Tris/EDTA buﬀer (20mM
Tris/HCl, 0.5mM EDTA, pH 7.5). A 30–55% (w/w) sucrose gradient
with centrifugation at 131,000×g for 16 h was used to separate the inner
membrane (IM) from the outer membrane [25]. The IM fraction was
collected from the gradient and washed with Tris/EDTA buﬀer via two
other 1-h centrifugations at 131,000×g. The protein concentration of
the IM fraction was determined via BCA assay, after which the IM ve-
sicles were resuspended in Tris/EDTA buﬀer and stored in 5mg/mL
protein aliquots at −80 °C. For SSBLM formation, the IM vesicles were
mixed with POPC liposomes at various ratios expressed as protein weight
of the IM versus dry lipid weight of the POPC vesicles. The resulting IM/
POPC mixture was then snap-frozen in liquid nitrogen and thawed by
immersing the test tube in water at 20 °C. This freeze-thaw procedure
was repeated three times after which the IM/POPC mixture was ex-
truded through a 200 nm track-etched membrane as described above.
NupC reconstitution
Reconstitution of His-tagged NupC into proteoliposomes was per-
formed following a modiﬁed method of Geertsma et al. [26]. POPC li-
posomes (5mg/mL) in PBS were prepared as detailed above using
200 nm track-etched membranes. 1 mL of liposomes was titrated with
10% (w/v) Triton X-100 until Rsat was reached (as monitored by an
increase in OD540 nm), after which an additional 5 μL of Triton X-100
were added. NupC was mixed in at a protein-lipid ratio of between 1
and 2.4% (w/w) and incubated for 15min at 20 °C. Bio-Beads SM-2
(50mg) were added to remove Triton X-100 from solution during a
30min incubation at 20 °C under gentle roller mixing. This step was
repeated twice using 60min and 16 h incubations at 4 °C, after which
the proteoliposomes were harvested via ultracentrifugation
(100,000×g for 1 h at 4 °C) and resuspended in PBS. Finally, the pro-
teoliposomes were re-extruded through 200 nm track-etched membrane
as described above.
SSBLM formation
Silica particles (typically 250 μg) were vigorously vortexed with li-
posomes at diﬀerent lipid-to-particle ratios (w/w), as indicated in the
Results section. Following a 1 h incubation at 20 °C with gentle roller
mixing, the resulting SSBLMs were pelleted via centrifugation (1min
17,000×g). The supernatants were removed (or transferred into sepa-
rate tubes, if required), while the particle pellets were washed by vor-
texing in identical volumes of deionised water, followed by a 30min
incubation at 4 °C with gentle roller mixing to remove any unbound lipid
materials. The washed SSBLMs were once again harvested by cen-
trifugation and resuspended in PBS prior to being used or stored at 4 °C.
Standard procedures were used for SDS-PAGE [27] and Western blot
analysis [28]. For Western blot analysis, SSBLM samples were mixed with
SDS-PAGE loading buﬀer (containing SDS) and incubated for 1–2 h at 37°
degrees to solubilise the membranes and embedded proteins. The silica
particles were removed by a short spin (1min 17,000×g) and the SDS-
PAGE loading buﬀer (supernatant) was used to load on the SDS-PAGE.
Cryo-electron microscopy (cryo-EM)
100 μL SSBLM samples were created as described above by mixing
His-tagged NupC/POPC proteoliposomes (2% (w/w) protein/lipid
ratio) with 200 nm silica particles at a 25% (w/w) liposome/particle
ratio. Protein-free particles were also formed at equivalent concentra-
tions to serve as negative controls. Following the deionised water wash,
the SSBLM samples were pelleted and resuspended in 100 μL volumes of
Ni-NTA-Nanogold probe solution, prepared to a 10:1 probe/protein
molar ratio in blocking buﬀer, consisting of PBS supplemented with
50 μg/mL POPC vesicles and 1mg/mL bovine serum albumin (BSA).
After a 30min incubation at 4 °C with gentle roller mixing, the SSBLMs
were pelleted and washed twice via vortexing, ﬁrst in blocking buﬀer,
then in regular PBS, before being diluted 10× further with PBS and
applied to the cryo-EM grids. These were prepared using a FEI Vitrobot
Mark IV by ﬁrst applying 3 μL of sample per grid (which had previously
been glow-discharged for 40 s), then blotting oﬀ the excess solution for
2 s and ﬁnally plunge-freezing the grids in liquid ethane. All of the
prepared cryo-grids were stored in liquid nitrogen prior to being im-
aged. The grids were imaged at a magniﬁcation of 35,000× using a FEI
Tecnai F20 transmission electron microscope (TEM) ﬁtted with a Gatan
4 K×4 K charge-coupled device (CCD) camera. All of the images were
collected in “low-dose” mode.
Small angle X-ray scattering (SAXS)
All small angle X-ray scattering (SAXS) measurements were per-
formed at 20 °C. The operated SAXS camera setup (SAXSpace, Anton
Paar, Austria) is described in great detail elsewhere [29]. Brieﬂy, a
high-resolution mode was chosen that allowed for the detection of a
minimum scattering vector, qmin, of 0.04 nm−1 (q = (4π/λ) sinθ,
where 2θ is the scattering angle and λ is the wavelength of the X-ray
beam, namely 0.154 nm). All studied samples were ﬁlled into the same
vacuum-tight, reusable 1mm quartz capillary, in order to give the exact
same scattering volume each time. A Mythen X-ray detector system
(Dectris Ltd., Baden, Switzerland) was used for recording the 1D scat-
tering patterns. SAXStreat software (Anton Paar, Graz, Austria) was
used to reﬁne the primary beam position. Background scattering from
water and capillary was subtracted using the SAXSQuant software
(Anton Paar, Graz, Austria).
Background subtracted SAXS patterns were analysed using an ex-
tended core shell model [30]. This model provides the scattering from a
spherical core (silica) and six concentric shell structures: ﬁve used to
build up the POPC bilayer and one for the space between the silica
sphere and the lipid bilayer (i.e. the intermediate water layer). All
electron densities were ﬁxed to literature values [31,32], with ρ(si-
lica)= 0.70 e/Å3, ρ(water)= 0.33 e/Å3, ρ(head group)= 0.45 e/Å3,
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ρ(CH2)= 0.30 e/Å3 and ρ(methyl)= 0.16 e/Å3. Additionally, the me-
thyl trough and head group thicknesses were ﬁxed to 0.5 nm and
0.8 nm, respectively. Thus, only three ﬁtting parameters were con-
sidered: (i) the silica radius, (ii) the intermediate water thickness and
(iii) the hydrocarbon chain length. The porosity of the Si-particles was
taken into account by determining the form factor contribution from
the nano-pores. For SAXS measurements, both SSBLM and negative
control (i.e. bare silica particle) solutions were created at concentra-
tions of 30mg/mL in deionised water. In order to get statistically reli-
able data and increased signal to noise ratio, we acquired 12 scattering
frames each with 30min exposure time and computed the average
curve for the further analysis.
Enzyme-linked immunosorbent assay (ELISA)
Freshly-made SSBLM particles, resuspended in either regular PBS
buﬀer or blocking buﬀer (i.e. PBS supplemented with 50 μg/mL POPC
vesicles and 1mg/mL BSA), were transferred to V-bottomed 96-well
plates and subsequently incubated with 100 μL volumes of HRP-con-
jugated anti-His antibodies (diluted 1:5000 (v/v) in PBS buﬀer) for 1 h
at 20 °C either in PBS or blocking buﬀer (10 μg/mL POPC vesicles and
1mg/mL bovine serum albumin (BSA)) in conical 96-well plates. The
particles were pelleted via centrifugation (3000×g, 2 min) and washed
twice in 100 μL volumes of PBS buﬀer (ﬁrst with and then without
50 μg/mL POPC liposomes (10min incubations at 20 °C). The washed
SSBLM pellets were resuspended in 50 μL of PBS buﬀer and transferred
onto a ﬂat-bottomed 96-well plate. Finally, each test well was supple-
mented with 50 μL of peroxidase assay working reagent (10-Acetyl-3,7-
dihydroxyphenoxazine, ADHP) and incubated for 30min at 20 °C before
the reaction was stopped through the addition of equivalent volumes of
0.5 MH2SO4. Fluorescence was measured at 590/10 nm in a ﬂuores-
cence plate reader, with excitation set to 545/10 nm.
Results
SSBLM formation
100- and 200 nm silica particles were mixed with ﬂuorescently-la-
belled POPC vesicles (100 nm) at diﬀerent ratios to determine the sa-
turation thresholds resulting in full lipid bilayer coverage of the parti-
cles (Fig. 1).
These measurements revealed that a minimal vesicle/particle ratio
of 30% (w/w) was necessary to saturate the 100 nm silica particles,
whereas their 200 nm counterparts appeared saturated beyond a ratio
of 15% (w/w). Such behaviour is expected considering that the surface-
to-volume ratio of particles scales linearly with their radius. Thus,
200 nm particles will have half the surface area of 100 nm particles
when normalised to the weight of silica. Consequently, about half the
amount of lipid material is needed to create SSBLMs on 200 nm parti-
cles compared to 100 nm particles.
While spectroﬂuorometry proved useful towards indicating whether
the POPC lipids were adhering to the silica particles to the point of
saturation, the results could not discriminate between correct SSBLM
formation and the simple attachment of lipid material to the available
silica surface. Therefore, small angle X-ray scattering (SAXS) and cryo-
electron microscopy (cryo-EM) were used for a more detailed char-
acterisation of the SSBLM particles. EM experiments are described
below for NupC-embedding SSBLMs.
The global ﬁtting analysis of the SAXS data comparing the bare si-
lica to the POPC-coated particles conﬁrmed a proper and intact lipid
bilayer coating. First, the bare silica particles radius (R) was determined
with a value of 47.9 ± 3.5 nm, consistent with the manufacturer's
speciﬁcations (Fig. 2A, red). Remarkably, a detailed look into the SAXS
proﬁles of the bare silica particles reveals further a deviation from the
expected Porod scattering of spheres (Fig. 2A, green). Note, the ob-
served additional weak and broad scattering around q=1.7 nm−1 is
the form factor contribution arising from nano-pores (Rg= 1.1 nm)
within the Si-particles.
Secondly, the SAXS data from the POPC-coated samples were then
ﬁtted with a ﬁxed silica particle radius of 47.9 nm applying an extended
core shell model (see Materials and Methods; Fig. 2A, purple). Not to
over-parametrize the model, we kept the number of ﬁtting parameters as
low as possible. Hence, all commonly known electron densities of the
modelled SSBLM layers were set to literature values and further the
methyl trough and head group thicknesses were also ﬁxed to 0.5 nm and
0.8 nm, respectively [31,32]. This means, only the radial dimensions of
the intermediate water layer thickness and the hydrocarbon chain length
were kept as free ﬁtting parameters (Fig. 2B). The ﬁtting results are
shown in panel A as solid lines and are in excellent agreement with the
recorded data points. The scattering contribution of the POPC bilayer
coating is most dominant in the range of 0.4 < q < 1.1 nm−1, in which
its form factor scattering contribution is recorded. Note, this q-range is
well separated from the highest scattering contribution arising from the
silica nano-pores, and hence, the evaluation of bilayer structure is un-
problematic. In conclusion, the SAXS data analysis supports the proper
and intact formation of the SSBLMs displaying a bilayer phosphate-to-
phosphate distance of the supported lipid bilayers to be 4.2 ± 0.3 nm at
20 °C, which within errors agrees with the previously reported value of
3.9 nm by Kučerka et al. [33]. The ﬁt also included the water layer for
which a thickness of 0.55 ± 0.01 nm was determined, thinner than the
1.7 nm determined by Bayerl et al. by NMR for SSBLMs [34]. However,
others have reported a large spread in the thickness of the water layer on
planer substrates (e.g., compare ref [35] with [36]), some with a
thickness between 0.2 and 0.8 nm [36].
Protein incorporation into SSBLMs
In order to embed membrane proteins into SSBLMs, fresh samples
were formed using NupC-containing proteoliposomes. His-tagged NupC
was ﬁrst reconstituted into POPC vesicles at a 2.4% (w/w) protein/lipid
Fig. 1. The ﬂuorescence emissions (A.U.) re-
sulting from 100 nm (left) and 200 nm (right) si-
lica particles enveloped in ﬂuorescently-labelled
POPC SSBLMs (red), as well as from the super-
natants obtained after pelleting the unwashed
particles (blue). The vesicle/particle ratio is given
in weight percent. The error bars represent the
standard error of the mean, n= 2. (For inter-
pretation of the references to colour in this ﬁgure
legend, the reader is referred to the Web version
of this article.)
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ratio and the resulting proteoliposomes were subsequently used in the
formation of both 100- and 200 nm NupC-embedding SSBLMs, as de-
scribed under Materials and Methods. The successful embedding of
NupC into the SSBLM was initially conﬁrmed via SDS-PAGE and wes-
tern blotting, using an HRP-conjugated anti-His antibody (Fig. 3). The
appearance of the bands conﬁrmed that NupC was indeed present
within the SSBLMs, while the intensity of the NupC bands from the
100 nm SSBLM samples was signiﬁcantly more intensive than that of
the 200 nm SSBLM, as expected, given the proportionate increase in
surface area (both SSBLM sample sizes used an identical amount of
silica particles, so the 100 nm particles have double the surface area of
the 200 nm).
Speciﬁc binding of antibodies and gold-conjugated Ni-NTA probes
The suitability of SSBLMs for selective screening was tested through
a peroxidase ELISA assay. Protein-free SSBLM particles were created for
negative control purposes. It should be noted that, in order to preserve
the structure of the SSBLMs, the antibody incubation step was per-
formed in the absence of detergents typical of traditional ELISAs (i.e.
Tween-20). Initial results revealed high background signals, due to non-
speciﬁc binding of the antibody to SSBLM, presumable as a con-
sequence of defects in the membrane coating, exposing the bare silica
[22]. However, non-speciﬁc binding of antibodies could be blocked via
the addition of 50 μg/mL POPC liposomes and 1mg/mL BSA during the
antibody incubation step. The 50 μg/mL POPC vesicles were added to
all of the subsequent washing steps to repair any defects in the mem-
brane layer that might arise during the assay [22]. The results obtained
using this optimised protocol minimised non-speciﬁc antibody binding
and conﬁrmed that SSBLM can be used to bind (and hence screen)
antibodies to membrane proteins in native-like lipid environment
(Fig. 4).
Using our optimised peroxidase assay protocol, we also tested
whether SSBLMs could be formed directly from total (i.e. “crude”) IM
extracts overexpressing our protein of interest, since such an approach
would prove highly beneﬁcial towards assaying membrane protein
targets that are diﬃcult to purify or reconstitute into lipid vesicles. We
have previously shown that to deposit solid-supported membranes on
planar glass or silica surfaces using crude bacterial membranes, such
extracts have to be ﬁrst mixed with liposomes (e.g. POPC liposomes) to
reduce protein content in the membranes [37]. POPC vesicles were thus
mixed via the freeze-thaw method with E. coli IM extracts over-
expressing His-tagged NupC at various ratios. Membrane extracts
overexpressing the untagged/wild-type construct of NupC were used as
negative controls. The results (Fig. 5) conﬁrmed that SSBLMs can also
be used as a screening platform when crude IM extracts, containing
high protein-to-lipid ratios, are used. The optimum ratio of bacterial IM
extracts to POPC liposomes lies between 20 and 40% (w/w), in line
with previous ﬁndings on planar surfaces [37], suggesting this optimal
ratio is independent on the target proteins that is studied. Fig. 5 shows
larger values for the standard error of mean when compared to Fig. 4.
Fig. 2. SAXS analysis of bare and POPC-coated
silica particles. (A) The scattering proﬁles re-
sulting from stock R∼ 48 nm silica particles (red)
and POPC SSBLMs (purple) alongside their cor-
responding ﬁt functions (solid lines). The green
dashed line shows the linear decay based on
Porod's law for scattering from ideal spheres. (B)
Reﬁned electron density proﬁle of our applied
SSBLM model. (For interpretation of the refer-
ences to colour in this ﬁgure legend, the reader is
referred to the Web version of this article.)
Fig. 3. Western blot of 100- and 200 nm POPC SSBLMs embedding His-tagged NupC. SSBLMs were prepared as described in the text at diﬀerent liposome/silica particle ratios as indicated
in the Figure. Identical weights of silica are used in the Western blot. Puriﬁed His-tagged NupC was used as positive control in lane 5 and quantitative band intensities are given.
Fig. 4. ELISA results (ﬂuorescence signals emitted) from 100 nm (red) and 200 nm (blue)
silica particles enveloped in protein-free POPC SSBLMs (control) or SSBLMs embedding
His-tagged NupC (NupC). Control and NupC SSBLMs were treated identically. The error
bars represent the standard error of the mean, n= 2. (For interpretation of the references
to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
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Comparing individual experiments shows that this is due to varying
amounts of target proteins incorporated from the crude membrane
extract into the SSBLM, as errors are similar to those in Fig. 4 when
ELISAs are performed on the same SSBLM batch. We propose that this is
due to the need to mix crude membrane extracts with POPC liposomes,
which might result in slight variations in incorporation of membrane
proteins into the SSBLMs, even when ﬁxed ratios of POPC versus crude
membrane extracts are used.
Although the western blot and ELISA experiments conﬁrmed the
presence of His-tagged NupC embedded onto the silica particles, these
two methods do not conﬁrm that the lipid bilayers were correctly
forming around the particles as compared to, for instance, intact ve-
sicles adsorbing to the surface of the particles. Indeed, the negative
eﬀects of membrane proteins on the formation of planar solid supported
membranes have previously been documented [38]. We note here,
however, that even if some of the vesicles are adsorbed to the spherical
silica particles intact, the system would still form a suitable screening
platform as indicated by the ELISA results. Nevertheless, in order to
further conﬁrm the correct formation of the SSBLMs, as well as to
provide a second method to show speciﬁc binding to embedded pro-
teins, we also imaged the SSBLM particles via cryo-EM.
EM samples were prepared using His-tagged NupC/POPC proteoli-
posomes (and protein-free POPC liposomes for the equivalent negative
controls) and subsequently incubated with Ni-NTA-Nanogold probes so
as to monitor the distribution of His-tagged NupC (Fig. 6). By rapidly
freezing the SSBLMs in vitreous ice, the lipid membrane structure is
preserved as opposed to negative staining, which can ﬂatten the spe-
cimens being studied. In order to further preserve the quality of the
images, a “low-dose” exposure procedure was used such that the elec-
tron radiation damage could be minimised. Under these conditions, the
discrete lipid membrane components of the SSBLMs could not be di-
rectly observed (in contrast to previous studies [15,39]), but the bound
Ni-NTA-Nanogold particles clearly indicated the location of the em-
bedded proteins on the surface of the SSBLMs, highlighted by the
multitude of representative black “dots”. The images show that Ni-NTA
binding was indeed speciﬁc to His-tagged NupC within the SSBLMs and
that membrane envelope the silica particles to form a SSBLM (i.e., not
adsorbed as intact proteoliposomes). We note, however, that for less
than 1 in 5 SSBLM particles, unfused vesicles were also visible. Two
examples of unfused vesicles are indicated by a red box in Fig. 6.
Analysing a number of EM images, a distribution of 5–60 Ni-NTA-
Nanogold were observed per silica particle, with an average of 30 Ni-
NTA-Nanogold/silica particle (S.D.= 18). Taking the diameter of the
silica particles as 200 nm, the molecular weight of NupC to be 44 kDa,
the surface area of POPC as 67 Å2 (MW 760 Da), it can be estimated that
130 NupC proteins are present for each silica particle (a 2% (w/w) ratio
of NupC to lipid was used to prepare the proteoliposomes). If NupC
adopts a random orientation on the silica particles, half of them will
have the His-tag facing outwards for the Ni_NTA-Nanogold to bind, i.e.
65 per silica. The lower average number of Ni-NTA-Nanogold that are
observed in the EM images could be due to incomplete binding of the
Fig. 5. ELISA results (ﬂuorescence signals emitted) from
100 nm (left) and 200 nm (right) silica particles envel-
oped in untagged NupC-expressing total membrane ex-
tracts (blue), as well as IM extracts overexpressing His-
tagged NupC (red). Both IM extracts were mixed with
POPC vesicles at diﬀerent ratios, as indicated. The error
bars represent the standard error of the mean, n= 3.
(For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the Web version of
this article.)
Fig. 6. Cryo-EM images of 200 nm silica particles coated with POPC SSBLMs with (top)
and without (bottom) embedded His-tagged NupC after incubation with 5 nm gold-con-
jugated Ni-NTA probes. The two red boxes in the top ﬁgure indicate two examples of
unfused vesicles. (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the Web version of this article.)
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Ni-NTA-Nanogold to the exposed his-tags or loss of NupC during the
reconstitution into proteoliposomes.
Discussion
A particular screening method that ﬁnds increasing use in both the
pharmaceutical and biotechnological ﬁelds is that based on phage
display. In principle, phage display screening can be performed using
detergent-solubilised membrane protein targets. However, detergent-
based screening methods come with their own drawbacks, including
target denaturation over long periods of storage or the inability to so-
lubilise certain membrane protein classes due to monomer packing
defects resulting in their aggregation and, ultimately, inactivation fol-
lowing puriﬁcation [40]. A ﬁnal problem with phage display screening
against membrane protein targets is the immobilisation strategy.
Globular proteins are typically adsorbed onto polymeric or streptavidin
coated surfaces. However, detergent solubilisation of membrane pro-
teins and the aforementioned problems with tagging can impede these
strategies. Several alternative strategies have been described, such as
whole cell panning [41] or embedding the proteins into nanodiscs [42].
Whole cells provide a very complex environment for screening while
nanodiscs still require the membrane proteins to be puriﬁed to a high
yield and purity.
By combining the attractive properties of both submicron materials
and model membranes, our proposed SSBLM particles aim to become an
improved antigen presentation method available to membrane protein
researchers. The successful embedding of NupC within the SSBLM
format on both 100 and 200 nm silica particles, along with conﬁrming
the accessibility of the embedded proteins towards high-aﬃnity anti-
body binding, both suggest that the SSBLMs could constitute a pro-
mising new means of studying membrane proteins in the future.
SSBLMs represent a versatile model system that not only mimics the
original cellular lipid environment, but also elegantly circumvents the
numerous disadvantages oﬀered by traditional detergent solubilisation
methods. Although the ‘shelf-life’ stability of the SSBLM was not studied
here, membrane proteins have previously been determined to be stable
of weeks in silica-supported membrane systems [43]. Therefore, we
believe that the platform could ultimately serve as an enhanced
screening support for the discovery of novel antibody binders in an
industrial setting, using high-throughput technologies, just as it has
already been considered for the role of delivering therapeutic payloads
to membrane protein targets via SSBLM-based nanovectors [39].
We note here that suitable liposome/particle ratios must be met in
order to avoid partially covered substrates, which can result in non-
speciﬁc binding. Just as importantly, the blocking of non-speciﬁc
binding sites and the washing of unbound materials must both be
carefully considered in order to reduce the chances of obtaining false
positive results. To this end, the format would greatly beneﬁt from a
faster washing procedure and one promising alternative would be to
assemble the SSBLMs on iron oxide-core, silica-shell particles, so as to
facilitate their magnetic separation from solution and thus eliminate the
platform's reliance on the more time-consuming centrifugation-based
pelleting. Superparamagnetic ferrite particles have already been cov-
ered with lipid bilayers in the past [39] and an added beneﬁt of other
such improvements would be the possibility for further automation
oﬀered by an industrial setting, which would ultimately allow the
SSBLMs to be used in high-throughput scenarios as well.
Other improvements could be considered for the use of SSBLMs in
screening assays. Some approaches enable the oriented reconstitution
of appropriately-tagged membrane proteins (e.g. His-tagged proteolipid
bilayers deposited onto Ni-NTA-treated surfaces [44]), while others are
better suited at preserving the functionality of the target proteins post-
puriﬁcation (e.g. SSBLMs for electrophysiology [45,46] or electro-
chemistry [47–53]). Any contact with a solid support can potentially
aﬀect protein ﬂuidity across the model membrane and, consequently,
prevent the uniform distribution of the designated antigen throughout
the chosen screening format. Several alternatives to the conventional
method of solid supported membrane formation via proteoliposomal
deposition have been trialled in an attempt at bypassing the problems
caused by protein immobility or improper membrane solubilisation
using detergents [7], such as the self-insertion of puriﬁed membrane
proteins into an already-formed solid supported membrane [15] or the
formation of a polyethylene glycol (PEG)-supported bilayer [54–56].
Conclusion
In conclusion, we have demonstrated that SSBLMs represent a
promising platform for screening assays, where membrane protein
targets are displayed embedded within a native-like lipid environment.
We have also demonstrated that SSBLMs can be quickly and easily
formed using puriﬁed proteins reconstituted into liposomes, as well as
by directly employing crude membrane extracts. Here, the potential
suitability of the SSBLM platform towards high-aﬃnity antibody
binding was established using ELISAs and cryo-EM imaging, where the
former technique showed that non-speciﬁc binding can be minimised
through suitable assay modiﬁcations. We are now investigating whe-
ther the SSBLM can be applied in phage display screening.
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